600267 海正药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.4707.312-1.1526.3566.969
总资产报酬率 ROA (%)2.9463.580-0.5122.5632.422
投入资产回报率 ROIC (%)3.6314.374-0.6363.1963.062

边际利润分析
销售毛利率 (%)44.98642.45641.54244.22242.736
营业利润率 (%)8.1126.9760.8905.9986.050
息税前利润/营业总收入 (%)8.5938.1911.0828.3158.429
净利润/营业总收入 (%)5.9085.719-0.9654.3174.415

收益指标分析
经营活动净收益/利润总额(%)137.021107.212-278.042113.40199.273
价值变动净收益/利润总额(%)-11.44119.849-90.002-11.15513.427
营业外收支净额/利润总额(%)-3.709-0.454207.9360.138-8.674

偿债能力分析
流动比率 (X)0.9480.9220.9660.8990.724
速动比率 (X)0.6650.6300.6690.6300.494
资产负债率 (%)42.84246.28952.59655.63862.086
带息债务/全部投入资本 (%)29.30034.15041.74543.84350.530
股东权益/带息债务 (%)235.354187.257134.380124.12991.799
股东权益/负债合计 (%)129.686112.82187.45877.33060.715
利息保障倍数 (X)11.1426.5690.5683.6012.945

营运能力分析
应收账款周转天数 (天)60.08364.24578.29071.94557.943
存货周转天数 (天)107.631113.488118.569111.653124.618